Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
Exponent Inc reports developments in science and engineering consulting, including financial results, client demand across its two operating segments, and capital-return actions. Its engineering and other scientific work includes failure analysis, dispute-related consulting, user research for consumer electronics, utility risk management, asset integrity, transportation, energy, construction, life sciences, and medical device support.
The company’s environmental and health segment is tied to chemical regulation, food safety, ecological and biological sciences, and environmental consulting. Recurring updates also cover quarterly dividends, share repurchase authorizations, conference calls, executive appointments, board matters, and governance changes.
Exponent, Inc. (Nasdaq: EXPO) announced a quarterly cash dividend of $0.24 per share, payable on June 24, 2022, to stockholders of record as of June 10, 2022. The firm confirmed its commitment to continuing quarterly dividends each year in March, June, September, and December. Dr. Catherine Corrigan, President and CEO, noted that this dividend reflects the strength of the company's balance sheet and business model, aimed at generating long-term shareholder value.
Exponent, Inc. (Nasdaq: EXPO) reported a 10.3% increase in total revenues for Q1 2022, reaching $128.5 million year-over-year, alongside a decrease in net income to $29.6 million or $0.56 per diluted share. EBITDA grew to $34.5 million, representing 29.2% of net revenues. The company anticipates mid-single digit growth for Q2 revenues and mid- to high-single digit growth for the full year 2022. Exponent continues to focus on expanding its engineering and scientific services across various sectors, particularly in consumer electronics and life sciences.
Exponent, Inc. (Nasdaq:EXPO) will announce its first quarter of fiscal year 2022 financial results on April 28, 2022, after market close. The conference call will begin at 4:30 p.m. ET, featuring CEO Dr. Catherine Corrigan and CFO Richard Schlenker. Investors can join the call via phone or through a live webcast available on the company’s investor relations site. Exponent specializes in engineering and scientific consulting, leveraging over 50 years of experience to provide solutions across 90 technical disciplines.
Exponent, Inc. (Nasdaq: EXPO) announced a $150 million expansion of its share repurchase program, increasing total available repurchases to approximately $179.5 million. The firm has repurchased $38.9 million of common stock in fiscal year 2022. CEO Dr. Catherine Corrigan expressed confidence in Exponent’s strategic direction and commitment to delivering shareholder value, noting a recent 20% increase in the quarterly dividend. Exponent ended fiscal 2021 with $297.7 million in cash and cash equivalents, supporting its robust capital allocation strategy.
Exponent, Inc. (Nasdaq: EXPO) reported a robust performance for Q4 and fiscal year 2021, with total revenue increasing 15% year-over-year to $466.3 million. Q4 revenues grew 9.9% to $113.5 million, although net income fell to $20.4 million from $21.8 million. EBITDA rose to $132.3 million, reflecting a 30.4% margin. The company announced an increase in its quarterly cash dividend from $0.20 to $0.24, highlighting strong demand for its engineering and environmental services. Looking ahead, Exponent anticipates mid- to high-single-digit revenue growth for 2022, but expects a decline in EBITDA margin.
Exponent, Inc. (Nasdaq: EXPO) announced a 20% increase in its quarterly dividend from $0.20 to $0.24 per share, payable on March 25, 2022, to shareholders of record by March 11, 2022. In 2021, the company returned $50.2 million to shareholders through dividends and stock repurchases, ending the year with $297.7 million in liquidity. CEO Dr. Catherine Corrigan emphasized the dividend hike reflects strong financial health and business resilience amid economic challenges. Exponent will continue its quarterly dividend payments every March, June, September, and December, subject to board approval.
Exponent, Inc. (Nasdaq:EXPO) will report its fourth quarter and fiscal year 2021 financial results on February 3, 2022, after market close. The announcement will be followed by a conference call hosted by CEO Dr. Catherine Corrigan and CFO Richard Schlenker at 4:30 PM ET. Investors can access the live call via phone or join the webcast from the Investor Relations section of Exponent's website. This call aims to provide insights into the company's financial performance and business developments for the fiscal year.
Summary not available.
Exponent, Inc. (Nasdaq: EXPO) announced that Dr. Catherine Corrigan and Richard Schlenker will present at the Berenberg US CEO Conference.
The conference is scheduled for Tuesday, November 9, 2021, from 12:00 PM to 12:45 PM PT. A webcast of the presentation will be available on the investor relations section of the Exponent website, with an archived replay accessible post-event.
Exponent provides engineering and scientific consulting solutions, leveraging over 50 years of experience in analyzing complex challenges.
Exponent, Inc. (Nasdaq:EXPO) has declared a quarterly cash dividend of $0.20 per share, payable on December 17, 2021, to shareholders of record as of December 3, 2021. The company plans to continue quarterly dividends each year in March, June, September, and December, contingent on Board approval. CEO Dr. Catherine Corrigan highlighted the company’s strong cash flow and balance sheet, affirming their commitment to high-quality data analytics and long-term shareholder value.